Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-28T00:53:55.892Z Has data issue: false hasContentIssue false
  • English
  • Français

Regulation of Trypanosoma cruzi infectivity by alpha- and beta-adrenergic agonists: desensitization produced by prolonged treatments or increasing agonist concentrations

Published online by Cambridge University Press:  06 April 2009

A. Ayala  and
F. Kierszenbaum
A. Ayala
Affiliation:
Department of Microbiology and Public Health, Michigan State University, East Lansing, Michigan 48824, USA
F. Kierszenbaum
Affiliation:
Department of Microbiology and Public Health, Michigan State University, East Lansing, Michigan 48824, USA
Get access Rights & Permissions [Opens in a new window]

Summary

We previously reported that blood forms of Trypanosoma cruzi express alpha- and beta-adrenergic receptors and that binding of specific agonists to these receptors modifies the infective capacity of the parasite in vitro. The present study has revealed that the inhibitory effect of the beta-adrenergic agonist L-isoproterenol and the stimulatory effect of the alpha-adrenergic agonist L-phenylephrine are not produced when the parasite is subjected to prolonged exposure to otherwise effective doses of these agonists or when supraoptimal doses of these agonists are used. We refer to these phenomena as ‘desensitization’ because of their analogy with vertebrate cells becoming desensitized by prolonged exposure to, or relatively high concentrations of, adrenergic agonists. At a constant agonist concentration, T. cruzi desensitization was time-dependent and, when the time of parasite treatment with the agonists was not changed, the higher concentrations of the agonist tested were the most effective in producing desensitization. The reduced infectivity resulting from treatment with optimal doses of L-isoproterenol was accompanied by elevated levels of cyclic adenosine mono- phosphate (cAMP) which were not detectable when L-isoproterenol concentrations producing desensitization were used. This finding implicated cAMP as a likely second signal in the inhibitory mechanisms of this agonist. No significant change in cAMP was detectable in parasites treated with L-phenylephrine, leaving open the question about how optimal doses of this alpha-adrenergic agonist enhance T. cruzi infectivity. Parasite responsiveness to alpha- and beta-adrenergic agonists as well as the desensitization effects define a system which regulates infectivity and could be modified at the host tissue level by naturally occurring agonists.

Keywords

Trypanosoma cruziChagas' diseaseadrenergic agonistsdesensitization
Type
Research Article
Information
Parasitology , Volume 100 , Issue 3 , June 1990 , pp. 429 - 434
Copyright
Copyright © Cambridge University Press 1990

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Budzko, D. B. & Kierszenbaum, F. (1974). Isolation of Trypanosoma cruzi from blood. Journal of Parasitology 60, 1037–8.CrossRefGoogle ScholarPubMed
Connelly, M. C., Ayala, A. & Kierszenbaum, F. (1988). Effects of alpha- and beta-adrenergic agonists on Trypanosoma cruzi interaction with host cells. Journal of Parasitology 74, 379–86.CrossRefGoogle ScholarPubMed
Connelly, M. C. & Kierszenbaum, F. (1984). Modulation of macrophage interaction with Trypanosoma cruzi by phospholipase A2-sensitive components of the parasite membrane. Biochemical and Biophysical Research Communications 121, 931–9.CrossRefGoogle ScholarPubMed
Connelly, M. C. & Kierszenbaum, F. (1985). Increased host cell- Trypanosoma cruzi interaction following phospholipase D treatment of the parasite surface. Molecular and Biochemical Parasitology 17, 191–202.CrossRefGoogle ScholarPubMed
Da Silveira, J. H., Zingales, B. & Colli, W. (1977). Characterization of an adenyl cyclase activity in particulate preparations of epimastigote forms of Trypanosoma cruzi. Biochimica et Biophysica Acta 481, 722–33.CrossRefGoogle ScholarPubMed
Exton, J. H. (1981). Molecular mechanisms involved in alpha-adrenergic responses. Molecular and Cellular Endocrinology 23, 233–64.CrossRefGoogle ScholarPubMed
Henriquez, D., Piras, R. & Piras, M. M. (1981). The effect of surface membrane modification of fibroblastic cells on the entry process of Trypanosoma cruzi trypomastigotes. Molecular and Biochemical Parasitology 2, 359–66.CrossRefGoogle ScholarPubMed
Kierszenbaum, F., Wirth, J. J., McCann, P. P. & Sjoerdsma, A. (1987). Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian cells. Proceedings of the National Academy of Sciences, USA 84, 4278–82.CrossRefGoogle Scholar
Lefkowitz, R. J., Stadel, J. M. & Caron, M. G. (1983). Adenylate cyclase coupled beta-adrenergic receptors: structure and mechanism of activation and desensitization. Annual Review of Biochemistry 52, 159–86.CrossRefGoogle ScholarPubMed
Mercado, T. I. & Katusha, K. (1979). Isolation of Trypanosoma cruzi from the blood of infected mice by column chromatography. Preparative Biochemistry 9, 97–106.CrossRefGoogle ScholarPubMed
Osuna, A., Ortega, G., Castanys, S. & Mascaro, M. C. (1984). Some factors affecting the in vitro invasion of HeLa cells by Trypanosoma cruzi. International Journal for Parasitology 14, 253–7.CrossRefGoogle ScholarPubMed
Piras, R., Piras, M. M., Henriquez, D. & Negri, S. (1982 a). Changes in morphology and infectivity of cell-culture derived trypomastigotes of Trypanosoma cruzi. Molecular and Biochemical Parasitology 6, 67–81.CrossRefGoogle ScholarPubMed
Piras, R., Piras, M. M., Henriquez, D. & Negri, S. (1982 b). The effect of inhibitors of macromolecular biosynthesis on the in vitro infectivity and morphology of Trypanosoma cruzi trypomastigotes. Molecular and Biochemical Parasitology 6, 83–92.CrossRefGoogle ScholarPubMed
Rangel-Aldao, R., Tovar, G. & Ledesma De Ruiz, M. (1983). The cAMP receptor protein of Trypanosoma cruzi. Journal of Biological Chemistry 258, 6979–83.CrossRefGoogle ScholarPubMed
Sibley, D. R. & Lefkowitz, R. J. (1985). Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature, London 317, 124–9.CrossRefGoogle ScholarPubMed
Torruella, M., Flawia, M. M., Elsenschlos, C., Molina, Y., Vedia, L., Rubinstein, C. P. & Torres, H. N. (1986). Trypanosoma cruzi adenylate cyclase activity. Purification and characterization. The Biochemical Journal 234, 145–50.CrossRefGoogle ScholarPubMed
Villalta, F. & Kierszenbaum, F. (1983). Role of cell surface mannose residues in host cell invasion by Trypanosoma cruzi. Biochimica et Biophysica Acta 736, 39–44.CrossRefGoogle ScholarPubMed
Wirth, J. J. & Kierszenbaum, F. (1982). Inhibitory action of elevated levels of adenosine-3′: 5′ cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction. Journal of Immunology 129, 2759–62.CrossRefGoogle ScholarPubMed
Wirth, J. J. & Kierszenbaum, F. (1983). Modulatory effect of guanosine-3′:5′ cyclic monophosphate on macrophage susceptibility to Trypanosoma cruzi infection. Journal of Immunology 131, 3028–31.CrossRefGoogle ScholarPubMed
Wirth, J. J. & Kierszenbaum, F. (1984 a). Macrophage mediation of the inhibitory effects of elevated levels of adenosine-3′:5′ cyclic monophosphate (cAMP) on macrophage- Trypanosoma cruzi association. International Journal for Parasitology 14, 401–4.CrossRefGoogle ScholarPubMed
Wirth, J. J. & Kierszenbaum, F. (1984 b). Fibronectin enhances macrophage association with invasive forms of Trypanosoma cruzi. Journal of Immunology 133, 460–4.CrossRefGoogle ScholarPubMed
Wirth, J. J. & Kierszenbaum, F. (1985). Stimulatory effects of leukotriene B4 on macrophage association with and intracellular destruction of Trypanosoma cruzi. Journal of Immunology 134, 1989–93.CrossRefGoogle ScholarPubMed
Zenian, A. & Kierszenbaum, F. (1982). Inhibition of macrophage—Trypanosoma cruzi interaction by concanavalin A and differential binding of bloodstream and cultured forms to the macrophage surface. Journal of Parasitology 68, 408–15.CrossRefGoogle Scholar
Zenian, A. & Kierszenbaum, F. (1983). Trypanosoma cruzi: differences in cell surface interaction of circulating (trypomastigote) and culture (epimastigote) forms with macrophages. Journal of Parasitology 69, 660–5.CrossRefGoogle ScholarPubMed
Zingales, B., Andrews, N. W., Kuwajima, V. J. & Colli, W. (1982). Cell surface antigens of Trypanosoma cruzi: possible correlation with the interiorization process in mammalian cells. Molecular and Biochemical Parasitology 6, 111–24.CrossRefGoogle ScholarPubMed
Zingales, B., Katzin, A. M., Arruda, M. W. & Colli, W. (1985). Correlation of tunicamycin-sensitive surface glycoproteins from Trypanosoma cruzi with parasite interiorization into mammalian cells. Molecular and Biochemical Parasitology 16, 21–34.CrossRefGoogle ScholarPubMed